Home > Boards > US Listed > Biotechs >

Blueprint Medicines Corporation (BPMC)

Add BPMC Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 4/16/2018 9:31:41 AM - Followers: 8 - Board type: Free - Posts Today: 0

Blueprint Medicines is a patient-driven oncology company developing highly selective kinase inhibitors for genomically defined cancer subsets. Led by a management team and advisors with world-renowned expertise in cancer genomics, drug discovery and clinical oncology, Blueprint has developed a platform that combines genomics with a novel library of kinase inhibitors, enabling Blueprint to rapidly develop potent highly selective compounds against clear genomic driver targets.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BPMC News: Current Report Filing (8-k) 04/16/2018 08:32:18 AM
BPMC News: Blueprint Medicines Publication in Cancer Discovery Highlights Preclinical and Clinical Proof-of-Concept Data for Highly Sele... 04/15/2018 09:35:00 AM
BPMC News: Blueprint Medicines Announces Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667 from Phase 1 ARROW Clinical Tr... 04/15/2018 09:30:00 AM
BPMC News: Statement of Changes in Beneficial Ownership (4) 03/21/2018 05:06:35 PM
BPMC News: Statement of Changes in Beneficial Ownership (4) 03/19/2018 05:07:58 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!